Maintenance of Clinical and Radiographic Benefit With Intravenous Golimumab Therapy in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy: Week‐112 Efficacy and Safety Results of the Open‐Label Long‐Term Extension of a Phase III, Double‐Blind, Randomized, Placebo‐Controlled Trial

By  

ARTHRITIS CARE AND RESEARCH, Vol. 67, Iss. 12, 2015-12 ,pp. : 1627-1636

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of ustekinumab on physical function and health-related quality of life in patients with psoriatic arthritis: a randomized, placebo-controlled, phase II trial

By Kavanaugh Arthur   Menter Alan   Mendelsohn Alan   Shen Yaung-Kaung   Lee Seina   Gottlieb Alice B.  

Current Medical Research and Opinion, Vol. 26, Iss. 10, 2010-10 ,pp. : 2385-2392

Informa Healthcare

Access to resources Recommend Favorite

Eslicarbazepine acetate as adjunctive therapy in patients with uncontrolled partial‐onset seizures: Results of a phase III, double‐blind, randomized, placebo‐controlled trial

By  

EPILEPSIA, Vol. 56, Iss. 2, 2015-02 ,pp. : 244-253

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical efficacy of collagenase Clostridium histolyticum in the treatment of Peyronie's disease by subgroup: results from two large, double‐blind, randomized, placebo‐controlled, phase III studies

By  

BJU INTERNATIONAL, Vol. 116, Iss. 4, 2015-10 ,pp. : 650-656

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comment on: A randomized placebo-controlled trial of methotrexate in psoriatic arthritis

By Sathi Navtej   Gladston-Chelliah Easwardhas   Chattopadhyay Chandrabushan  

British Journal of Rheumatology , Vol. 52, Iss. 4, 2013-04 ,pp. : 761-761

Oxford University Press

Access to resources Recommend Favorite